Please login to the form below

Not currently logged in
Email:
Password:

Servier defends Perindopil overcharging claim

Servier refutes claims made by the UK's Department of Health the company is overcharging for high blood pressure and heart disease drug Perindopil

Servier is contesting legal action by the UK's Department of Health (DH), which claims the French drug manufacturer charged £220m too much for its high blood pressure and heart disease drug perindopril.

A report in the UK paper, the Daily Mail, alleges that Health Secretary Andrew Lansley has accused Servier of forcing doctors to pay for expensive versions of the pills when generic ones were available.

Lansley also alleges that the company paid millions of pounds to rivals not to make generic versions, after its patent ran out in 2001, according to the report.

Lansley is leading the action at the High Court with ten strategic health authorities and 157 primary care trusts to reclaim money the NHS was overcharged between 2001 and 2007.

A spokeswoman for Servier said: "We are contesting the claim and we are confident that the right outcome will be reached."

Meanwhile a spokeswoman for the DH told PMLiVE that the department could not comment on ongoing proceedings.

Earlier this year Lansley took legal action against Reckitt Benckiser, claiming nearly £90m for overcharging for heartburn drugs.

7th June 2011

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics